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Abstract
Background: Salmonella enterica serotype Paratyphi A is a human-restricted cause of paratyphoid fever, accounting for up
to a fifth of all cases of enteric fever in Asia.
Methodology/Principal Findings: In this work, we applied an RNA analysis method, Selective Capture of Transcribed
Sequences (SCOTS), and cDNA hybridization-microarray technology to identify S. Paratyphi A transcripts expressed by
bacteria in the blood of three patients in Bangladesh. In total, we detected 1,798 S. Paratyphi A mRNAs expressed in the
blood of infected humans (43.9% of the ORFeome). Of these, we identified 868 in at least two patients, and 315 in all three
patients. S. Paratyphi A transcripts identified in at least two patients encode proteins involved in energy metabolism,
nutrient and iron acquisition, vitamin biosynthesis, stress responses, oxidative stress resistance, and pathogenesis. A number
of detected transcripts are expressed from PhoP and SlyA-regulated genes associated with intra-macrophage survival, genes
contained within Salmonella Pathogenicity Islands (SPIs) 1–4, 6, 10, 13, and 16, as well as RpoS-regulated genes. The largest
category of identified transcripts is that of encoding proteins with unknown function. When comparing levels of bacterial
mRNA using in vivo samples collected from infected patients to samples from in vitro grown organisms, we found significant
differences for 347, 391, and 456 S. Paratyphi A transcripts in each of three individual patients (approximately 9.7% of the
ORFeome). Of these, expression of 194 transcripts (4.7% of ORFs) was concordant in two or more patients, and 41 in all
patients. Genes encoding these transcripts are contained within SPI-1, 3, 6 and 10, PhoP-regulated genes, involved in energy
metabolism, nutrient acquisition, drug resistance, or uncharacterized genes. Using quantitative RT-PCR, we confirmed
increased gene expression in vivo for a subset of these genes.
Conclusion/Significance: To our knowledge, we describe the first microarray-based transcriptional analysis of a pathogen in
the blood of naturally infected humans.
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Salmonella enterica serotype Paratyphi A (S. Paratyphi A) is an
emerging food and water-borne pathogen that currently accounts
for approximately 1 in 5 cases of enteric fever in South Asia [1,2].
Although previously thought to cause a milder illness than
Salmonella enterica serotype Typhi (S. Typhi), recent studies suggest
that S. Paratyphi A causes a clinical syndrome quite similar to that
caused by S. Typhi [1,3]. Over the past decade, S. Paratyphi A
isolation rates have increased throughout South Asia, along with
antimicrobial resistance [1,3–6]. The reasons for this emergence of
S. Paratyphi A are unclear, and may relate in part to secondary
effects of vaccine programs targeting S. Typhi [6]. No commer-
cially available vaccine protects against S. Paratyphi A infection,
although some protection against S. Paratyphi B is provided by the
oral live attenuated typhoid vaccine strain Ty21a (a derivative of S.
Typhi wild type strain Ty2) [1,7,8]. Increasing rates of infection,
the lack of a commercially available vaccine effective against S.
Paratyphi A infection, and steadily increasing resistance of S.
Paratyphi A to antimicrobial agents make S. Paratyphi A infection
a growing public health concern.
Following oral ingestion, S. Paratyphi A organisms invade
intestinal epithelial cells, are taken up by gut-associated lympho-
reticular tissues, and enter the systemic circulation. In the
bloodstream, a majority of organisms reside within professional
phagocytic cells, while the remainder are extracellular [9]. S.
Paratyphi A studies have been limited by both a lack of an
adequate animal model, and the low number of microorganisms
present in the blood of infected individuals (estimated at 0.1–
10,000 Salmonella organisms per ml of blood) [9–11]. Most of what
is known about the pathogenesis of S. Paratyphi A has, therefore,
been extrapolated from studies with S. Typhi and S. Typhimur-
ium, and comparative genomic analyses [12–21].
To begin to address pathogen-host interactions during this
unique human-restricted infection, we applied a transcript capture
and amplification technique, Selective Capture of Transcribed
Sequences (SCOTS) [22], along with microarray technology, to
assess whether we could detect S. Paratyphi A mRNA directly in
the blood of bacteremic patients. To identify genes whose
expression might be potentially regulated in vivo, we also compared
the relative level of bacterial genes detected in vivo to those detected
using the same technique on in vitro grown organisms. We then
used RT-qPCR to validate expression of genes detected in our
screen.
SCOTS has previously been used in gene expression studies of a
number of organisms, including analyses of S. Typhi, S.
Typhimurium, and Mycobacterium tuberculosis, using ex vivo human
macrophage models [13,14,16,23]. SCOTS has also been applied
to evaluate bacterial gene expression in Helicobacter pylori in gastric
mucosa biopsies of infected humans, and Hemophilus ducreyi in
pustules of infected humans [24,25]. To our knowledge, however,
no previous study has used this approach to assess bacterial gene
expression directly in the blood of infected humans.
Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. We obtained written consent from
each patient prior to participation. Written informed consent was
obtained from parents authorizing the participation of their
children in the study and assent was obtained from children
greater than 5 years old. This study was approved by the ethical
and research review committees of the ICDDR,B and the Human
Research Committee of Massachusetts General Hospital.
Study subject selection, sample collection, and recovery
of organisms
Individuals (3–59 years of age) presenting to the International
Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B)
Hospital or Dhaka Medical College Hospital with fever of 3–7
days duration ($39uC), without an obvious focus of infection, and
lacking an alternate diagnosis were eligible for enrollment. After
obtaining written consent, we collected venous blood (5 ml from
children ,5 years, and 10 ml from all others), and immediately
placed 2 ml of blood into TRIzol (Invitrogen Life Technologies,
Carlsbad, CA) at a 1 (blood):2 (TRIzol) volume ratio. We mixed
these samples and stored them at 270uC for later analysis. We
next cultured 3–5 ml of day 0 blood using a BacT/Alert
automated system, sub-culturing positive bottles on MacConkey
agar, and identifying isolates using standard biochemical tests and
reaction with Salmonella specific antisera [26]. Following collection
of blood, patients were initially treated with oral ciprofloxacin or
cefixime, or injectable ceftriaxone, and antibiotics were continued
for up to 14 days at the discretion of the attending physician.
cDNA synthesis and amplification
To create cDNA of organisms in the blood of bacteremic
patients (in vivo sample), we used TRIzol preserved blood samples
of patients whose day 0 culture subsequently grew S. Paratyphi A.
To generate corresponding in vitro cDNA samples, we grew each
patient’s bacterial isolate in Luria Bertani (LB) broth until mid-log
growth phase (OD600 0.45–0.6), and then immediately placed
these samples into TRIzol at a 1 (mid-log culture):2 (TRIzol)
volume ratio. We recovered total RNA from TRIzol preserved in
vivo and in vitro samples per manufacturer’s instructions (Invitro-
gen), and treated with DNase I on RNeasy columns (Qiagen). We
converted 5 mg of total extracted RNA into cDNA using random
priming (T-PCR) to obtain a representative amplifiable double-
stranded cDNA population as described by Froussard et al. [27],
with modifications as previously described by Graham et al. [23].
Briefly, we used Superscript III (Invitrogen) to synthesize first
strand cDNA with K9RNA (for in vivo sample) or F9RNA (for in
vitro sample) primers with a defined 59 end terminal sequence and
a random nonamer at the 39 end (Supplementary Table S1). We
then synthesized second strands using the same primers and
Klenow fragment (Invitrogen) according to manufacturer’s
instruction. We then PCR-amplified double stranded cDNA with
K9 primer lacking random terminal residues for in vivo samples,
and F9 primer for in vitro samples for a total of 30 cycles (94uC for
Author Summary
Salmonella enterica serotype Paratyphi A is a significant
and emerging global public health problem and accounts
for one fifth of all cases of enteric fever in many areas of
Asia. S. Paratyphi A only infects humans, and the lack of an
appropriate animal model has limited the study of S.
Paratyphi A infection. In this study, we report the
application of an RNA analysis method, Selective Capture
of Transcribed Sequences (SCOTS), to evaluate which S.
Paratyphi A genes are expressed directly in the blood of
infected humans. Our results provide insight into the
bacterial adaptations and modifications that S. Paratyphi A
may need to survive within infected humans and suggest
that similar approaches may be applied to other patho-
gens in infected humans and animals.
SCOTS Paratyphi A
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initial denaturation at 94uC for 2 minutes).
Genomic DNA biotinylation and rRNA blocking-plasmid
construction
SCOTS requires capturing bacterial cDNA from a mixture of
host and microbial nucleic acid by solution-phase hybridization to
biotinylated bacterial genomic DNA (gDNA) [23]. To generate
gDNA, we grew one of the S. Paratyphi A clinical isolates to mid-
logarithmic growth phase in LB at 37uC, and purified gDNA using
Easy DNA (Invitrogen). We then biotinylated extracted gDNA
with photobiotin acetate (Sigma), and sonicated as previously
described [22]. To minimize capture of cDNA of ribosomal RNA
by biotinylated gDNA, we blocked ribosomal RNA encoding
sequences in the gDNA by pre-hybridizing with sonicated DNA
fragments from plasmids encoding 16S and 23S cognate rRNA.
To generate these plasmids, we PCR-amplified S. Paratyphi A 16S
and 23S rRNA genes, and cloned these products into pKK223-3
to generate pRibDNA_PTA.
SCOTS
We performed three rounds of SCOTS on in vivo and in vitro
cDNA samples, separately, as previously described [23]. Briefly,
we mixed denatured biotinylated S. Paratyphi A gDNA with
blocking pRibDNA_PTA, and added this denatured mixture to
cDNA samples, hybridizing samples overnight at 67uC. We
captured biotinylated gDNA-cDNA hybrids using streptavidin-
coated magnetic beads (Dynal M-280). After washing samples, we
eluted captured cDNA with NaOH, PCR-amplified in vivo and in
vitro cDNA samples with K9 or F9 primers, respectively, and
purified products using Qiagen PCR column purification kits. We
performed three hybridization and amplification cycles to obtain
bacterial cDNAs for microarray hybridization.
cDNA hybridization-microarray analysis
We differentially labelled in vivo and in vitro SCOTS-cDNAs
for each of the three patients with S. Paratyphi A bacteremia [28],
and added these products to activated Salmonella ORF microarray
glass slides (version STv7S; McClelland Laboratory, Vaccine
Research Institute of San Diego, CA, http://www.sdibr.org/
Faculty/mcclelland/mcclelland-lab), as previously described [13,29].
Microarrays contained gene-specific PCR-products of 4,271 ORFs
from Salmonella enterica strains including $97% identical orthologues
of more than 95% of annotated S. Paratyphi A SARB42 genes. We
performed labeling and hybridization in duplicate, with dye
reversals. We quantified signal intensities using ScanArray software
(ScanArray express, version 3.0.1). To assess potential biases in
identifying potentially differentially in vivo-expressed genes, we also
probed slides comparing SCOTS-product generated from in vivo
samplesto labeled cDNA fromin vitro samples towhichSCOTS was
notapplied. Additionally, wedirectlycompared in vitrocDNAsslides
to which SCOTS was and was not applied using analyses described
below and similar to Faucher et al. [13], which confirmed that no
significant biases were introduced using this approach.
For analyses, we subtracted local background from spot signal
intensities, and considered a cDNA for an ORF detected in a
particular sample if it met the following criteria: 1) the median
signal intensity of at least 2 of its 3 replicate spots on the array was
at least ten median absolute deviations greater than the median of
spots on the microarray corresponding to genes absent from the S.
Paratyphi A genome, and 2), this criterion was met on greater than
75% of slides for that subject. We then evaluated differences in
expression in in vitro versus in vivo grown organisms for all genes
detected in in vivo samples. Using LOESS-normalized, log-
transformed data, we employed repeated measures ANOVA (to
within slide replicate spots) with fixed type (in vivo versus in vitro)
and dye effects with Benjamini-Hochberg correction. We only
considered array features with a coefficient of variation in signal
intensity of less than 50% within an array. We considered
significant variations in signal intensity as determined by ANOVA
indication of genes potentially differentially expressed in vivo versus
in vitro. We deposited data in the NCBI Gene Expression Omnibus
(GEO, www.ncbi.nlm.nih.gov/geo), accessible through GEO
accession number GSE22958. Functional classification of genes
was based on J. Craig Venter Institute annotations (http://cmr.
jcvi.org/tigr-scripts/CMR/CmrHomePage.cgi).
Quantitative PCR analysis
We selected a subset of genes identified in our microarray
analyses for confirmation by quantitative real time PCR (RT-
qPCR). We compared steady state mRNA levels in specimens from
two of the patients analyzed by SCOTS-array hybridization, and
twoadditionalpatientsbacteremicwithS.ParatyphiAthatwerenot
included in the SCOTS analyses. We compared in vivo expression
levels to those present in in vitro samples using three bench-top
culture replicates of the S. Paratyphi A isolate from Patient 3 grown
to mid-logarithmic phase in LB, as described above. We included in
our selection criteria several genes of interest with high baseline
signals and fold-changes by SCOTS-array analysis. For compari-
son, we used SPA3294 (encoding 50S ribosomal protein L5) as a
housekeeping gene with no differential detection by SCOTS-array
analysis. We had insufficient sample from patient #1 to perform
RT-qPCR for all selected genes, and for this individual, we
performed RT-qPCR for only three of the six selected genes. We
used SuperScript II (Invitrogen) with random hexamers (Sigma),
according to manufacturer’s instructions to generate cDNA, and
performed RT-qPCR analysis using iQ SYBR Green Supermix
reagent (Bio-Rad; Hercules, CA) and a CFX96 Real-time PCR
detection system (Bio-Rad; Hercules, CA), as previously described
[30]. Primers are listed in Table S1. For each sample, we used no-
template controls and samples lacking reverse transcriptase as
baseline reactions. After initial denaturation at 95uC for 3 min, the
RT-PCR cycle was as follows: denaturation at 94uC for 30 seconds
(s), extension at 58uC for 30 s, extension at 72uC for 1 minute,
followed by a plate read. We repeated the cycle 40 times, set the
calculated threshold cycle (CT) in the low/linear portion of product
curves, and quantified gene copy numbers using pGEM-T Easy-
based plasmids (Promega) containing the gene of interest [30]. We
calculated control gene copy numbers using plasmid size and A260
readings, and normalized gene copy numbers against cDNA copies
of 16S rRNA. We assessed singularity of product species and size by
melting curve analysis.
Results
Detection of S. Paratyphi A mRNA in the blood of
infected humans
We isolated serotype Paratyphi A in the blood of 5 of 89
individuals who met study criteria. In total, we detected transcripts
of 1798 S. Paratyphi A genes in the blood of infected humans, or
43.9% of ORFs in the S. Paratyphi ATCC9150 genome. Of these,
we detected 868 transcripts in at least two patients, and 315 in all
three patients (Figure 1A and Table S2). Detected transcripts are
predicted to encode products that could be categorized into a
number of functional groups (Figure 2A). The largest grouping was
‘‘unknown/unclassified’’ (338 transcripts; 18.8% of detected
mRNA/cDNAs; 8.3% of S. Paratyphi A ORFs). Other large
SCOTS Paratyphi A
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esis (phoQ, rpoS), nutrient acquisition, energy metabolism, biosyn-
thesis of the essential vitamins biotin (bioABF, thiJ) and thiamine
(thiC), iron acquisition (genes in the iroA cluster, fepBDE, ybdA) and
stress responses (htrA, groEL, groES, dnaK) including oxidative stress
resistance (katE, umuCD). Forty-three of the transcripts correspond-
ed to genes contained within Salmonella Pathogenicity Islands (SPIs)
1–4, 6, 10, 13, and 16 (annotated in column E of Table S2).
Comparison of levels of S. Paratyphi A transcripts
detected using in vivo versus in vitro samples
mRNA/cDNA of 11 genes were detected only in in vivo samples
ofatleast2patients,andnotdetectedinanyinvitrosample(Table1).
These included transcripts of genes involved in biosynthesis of
essential vitamins such as biotin (bioF), utilization of alternative
carbon sources including ethanolamine (eut operon) and propane-
diol (pdu operon), iron acquisition (fepD), and resistance to
antimicrobial agents (yegO, also known as mdtC). When considering
genes whose expression was detected by SCOTS array in both in
vivoandinvitrosamples,weidentifiedtranscriptsof910genes(22.3%
of ORFs) with significant and at least 2-fold difference in signal
detection between in vivo versus in vitro samples: 347, 367, and 443 in
patients 1, 2, and 3, respectively (Figure 1B and annotated in
column Y, AS, and AE of Table S2). We detected transcripts of 206
genes in at least two patients, expression of 194 of which were
concordant (4.7% ORFs), and 41 in all three patients (Table 2). We
categorized the 194 concordant gene products detected in at least
two patients into a number of functional groups (Figure 2B). The
largest grouping was ‘‘unknown/unclassified’’ (44 genes). We
identified transcripts of 12 genes were located within SPIs (SPI-1,
3, 6, 10, 16) [12,31–34], a number of transcripts corresponded to
genes within the PhoP/Q regulatory system involved in intra-
macrophage survival [20,35–37], and five genes were in phages
unique to S. Paratyphi A, including SPA-2 and SPA-3-P2 [12].
Quantitative Real Time-PCR analysis
To further analyze expression levels of genes identified in our
screen, we used quantitative RT-PCR to assess relative steady state
mRNA levels for some of the genes of interest identified by
SCOTS-array. We chose five genes with high baseline signals and
difference in detection signal by SCOTS-array analysis. These
included SPA0410 (eutB), encoding an ethanolamine ammonia
lysase; SPA1451 (sseE), encoding a secreted effector protein and
located within SPI-2; SPA2748 (spaP), encoding a secreted protein
located within SPI-1; SPA3315 (yheL), encoding a sulfur transfer
complex subunit; and SPA3373, a putative cytoplasmic protein.
We also assessed SPA3294 transcript levels, encoding ribosomal
protein L5, as a representative housekeeping gene. We performed
RT-qPCR analyses using blood collected at the initial clinical
encounter and immediately preserved in TRIzol. We had
sufficient sample to perform RT-qPCR on initial blood samples
of SCOTS patients 1 and 3, and performed additional RT-qPCR
analysis on two additional patients bacteremic with S. Paratyphi A
whose blood samples were not analyzed by SCOTS-cDNA
hybridization (patients 4 and 5). As shown in figure 3, we found
significantly increased expression of all five analyzed candidate
genes in vivo, but not for housekeeping gene SPA3294.
Discussion
S. Paratyphi A now accounts for a fifth of all cases of enteric
fever in many areas of Asia, and it is therefore a significant and
emerging global public health concern. S. Paratyphi A in vivo
biology is difficult to study due to a lack of an animal model that
fully replicates human infection. In this study, we used an mRNA/
cDNA capture and amplification technique, microarray technol-
ogy, and quantitative PCR to detect S. Paratyphi A transcripts in
the blood of bacteremic patients in Bangladesh. We identified a
subset of S. Paratyphi A genes with higher level of transcription in
vivo compared to in vitro samples, suggesting possible in vivo
induction of these genes, and we confirmed increased in vivo
expression of a subset of these genes using RT-qPCR. SCOTS
and SCOTS/microarray technologies have previously been used
to analyze S. Typhimurium and S. Typhi gene expression using ex
vivo models [13,14,16,18], but to our knowledge, no group has
used this or a similar technology to assess bacterial gene expression
directly in the blood of bacteremic patients, and no group has
assessed S. Paratyphi A gene expression in various conditions.
We could categorize the 868 S. Paratyphi A genes expressed in
the blood stream of two or more bacteremic patients into a
number of groupings that may reflect transcriptional adaptations
Figure 1. Salmonella Paratyphi A genes whose mRNA/cDNA was detected in the blood of infected humans. Venn diagram of (A) number
of transcripts of S. Paratyphi A genes detected in each patient, and (B) subset with significantly different levels of detection by SCOTS-array
comparing in vivo to in vitro samples.
doi:10.1371/journal.pntd.0000908.g001
SCOTS Paratyphi A
www.plosntds.org 4 December 2010 | Volume 4 | Issue 12 | e908of S. Paratyphi A to the in vivo environment. These include
adaptations involved in intra-macrophage survival, for example
altering energy metabolism, nutrient acquisition, and resisting
both oxidative killing and antimicrobial peptides. Forty-three
expressed genes were located within known Salmonella Pathoge-
nicity Islands including SPI 1-4, 6, 10, 13, and 16 [12,31–34].
Figure 2. Functional classifications of products of S. Paratyphi A genes whose mRNA/cDNA was detected in this study. Functional
classification of products of transcripts (A) detected in in vivo samples in two or more patients, and (B) associated with significantly different levels of
detection in in vivo versus in vitro samples in two or more patients using SCOTS-array.
doi:10.1371/journal.pntd.0000908.g002
SCOTS Paratyphi A
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epithelial cell invasion [38]. Our identification of SPI-1 gene
transcripts in the blood stream of infected humans, including genes
of the sip and spa gene clusters, suggests a potential role for these
genes in eukaryotic cell invasion outside of the intestinal
epithelium. SPI-2 encodes a type III secretion system (TTSS) that
is involved in survival of Salmonella within macrophages, including
creating and maintaining Salmonella-containing vacuoles (SCV)
[39]. Among the SPI-2 genes detected in our analyses were TTSS-
associated and effector genes contained within the ssa and sse
operons. SPI-3 also contains a number of genes involved in
pathogenesis. We detected in vivo expression of the mgtBC operon,
encoding a magnesium transporter, within this island, and
magnesium availability is a key signal for Salmonella in the
intracellular environment [40]. Transcription in this operon is
regulated by PhoPQ and is required for survival within
macrophages and low Mg
2+ conditions [40]. We also identified
the transcript of the SPI-3-associated gene misL, an autotranspor-
ter possibly involved in cellular adhesion [41]. Within SPI-4, we
detected in vivo expression of siiE, an adhesin that aids in efficient
translocation of SPI-1 effectors through involvement in apical
membrane ruffling of epithelial cells [42]. SPI-6 appears to be
involved in intra-macrophage survival, including encoding pro-
teins involved in metabolic pathways, nutrient acquisition, and
utilization of alternate carbon sources within macrophages [43].
Our identification of ybeJ involved in carbohydrate transport and
metabolism is consistent with this model. SPI-6 also encodes a
number of fimbrial proteins involved in adherence and virulence
in a number of Salmonella animal models [44], and we identified
transcripts of tcfBC and safC, encoding fimbrial proteins,
supporting the proposal that these factors may play a role at
various stages of Salmonella infection. Faucher et al. identified SPI-
10 in their application of SCOTS to S. Typhi within ex vivo
macrophages [14], and we also detected a number of transcripts of
S. Paratyphi A genes within SPI-10, many of which are
uncharacterized. Interestingly, SPI-10 is present in S. Typhi and
S. Paratyphi A, but absent from most strains of S. Typhimurium
and all strains of S. Paratyphi B and S. Paratyphi C examined to
date [45]. We also detected transcripts of three genes (uxaC, exuT,
SPA2997) contained within the conserved portion of SPI-13, and
gtrB, involved in O-antigen glycosylation, and contained within
SPI-16 [31].
We detected mRNA/cDNA of a number of genes expressed
under the control of major virulence regulatory systems in
Salmonella, including the PhoP, RpoS, and SlyA systems involved
in intra-macrophage survival and virulence [35,46,47]. Within the
PhoPQ cascade, we detected transcripts of phoQ itself; lpxO,a
dioxgenase involved in lipid synthesis [20]; mgtBC; mgtA, a possible
pseudogene in S. Paratyphi A [36]; virK encoding the VirK
virulence protein [37]; and bioBF involved in biotin synthesis [20].
Within the RpoS regulatory cascade, we detected transcripts of
rpoS itself, katE and xthA involved in resistance to oxidative stress
[48,49], and narZYV involved in nitrate reduction [48,50]. Of note,
mutations in the narZ operon are associated with decreased
virulence of S. Typhimurium in mice [50]. Within the SlyA-
regulatory system also involved in intra-macrophage survival of
Salmonella, we detected expression of groEL, a chaperone protein
also regulated by PhoP [40,51].
Many of the genes that we identified as in vivo expressed and
potentially differentially expressed (compared to ex vivo conditions)
are associated with adaptation to the likely nutrient-altered
environment of the macrophage. For instance, we detected
mRNA of 7 of the 17 genes of the eut operon involved in
ethanolamine utilization, providing alternate sources of carbon
and/or nitrogen [52]. We also detected expression of the pduBGJK
genes involved in alternate carbon source propanediol utilization
[43], and genes involved in citrate and tartrate fermentation,
including oxaloacetate decarboxylase genes oadA and oadB [53]. Of
note, oadA mutants of Legionella pneumophila have impaired
replication and survival within macrophages [54]. We detected
transcripts of dmsC, encoding a dimethyl sulfoxide reductase
involved in bacterial survival in anaerobic conditions, similar to
that probably encountered within Salmonella-containing vacuoles,
and genes involved in the response to phosphate-limited
conditions, including the phosphate transporter genes ugpAE and
pstCA-phoU [55].
S. Paratyphi are becoming increasingly resistant to antimicro-
bial agents, especially in Asia [4], and all S. Paratyphi A strains
isolated in this study were resistant to nalidixic acid and
intermediately susceptible to ciprofloxacin, despite the fact that
no antibiotics were administered prior to collection of blood in this
study. In our analysis, we detected mRNA/cDNA of several
bacterial genes in in vivo samples involved in resistance to a number
of antimicrobial agents, including nalidixic acid, novobiocin,
tetracycline, and norfloxacin [56]. Mechanisms of resistance
encoded by detected genes included alteration of target molecules
such as the protein encoded by bacA that confers resistance to
bacitracin [57], and multidrug efflux systems of the resistance-
nodulation-division (RND)-type systems (acrB, sapC, yegO/mdtC)
and the major facilitator system (smvA, emrA) [56,58].
Of the 1798 in vivo-expressed genes identified, 910 had
statistically significant differences in signal detection when
comparing in vivo to in vitro samples (approximately 50% of
detected transcripts; 22.2% of S. Paratyphi A ORFs); a figure in
concordance with the 36% identified in an ex vivo macrophage
model of S. Typhi by Faucher et al. [13]. 194 were concordantly
differentially detected in at least two patients, and 41 in all three
patients. Many of these 41 genes are involved in energy
metabolism, including eutEJABC, pduG, and acpP; survival in metal
ion limiting conditions including the Mn
2+ transport-associated
gene mntH; and biosynthesis of essential molecules, including thiC
involved in thiamine synthesis. Interestingly, we also identified
transcripts of spaP at higher levels of detection in all in vivo versus in
vitro samples, and subsequently confirmed this increased expression
in vivo using RT-qPCR. spaP is contained within SPI-1 and is
thought to be involved in invasion of epithelial cells. Our results
Table 1. S. Paratyphi A (SPA) genes whose transcripts were
detected only in in vivo samples of at least two patients and
not in any in vitro sample.
SPA locus SPA gene SPA description
SPA0405 eutE Putative aldehyde dehydrogenase
SPA0612 ccmC Heme exporter protein C1
SPA0737 yegO Putative RND-family transporter protein
SPA0826 pduJ Putative propanediol utilization protein PduJ
SPA1856 cspD Cold shock-like protein CspD
SPA1957 bioF 8-amino-7-oxononanoate synthase
SPA2142 fepD Ferric enterobactin transport protein
SPA2483 - Conserved hypothetical protein
SPA2570 - Putative phage baseplate assembly protein
SPA2574 - Putative membrane protein
SPA3456 - Putative uncharacterized protein
doi:10.1371/journal.pntd.0000908.t001
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vivo to in vitro samples using SCOTS/microarray.
Main Role
SPA
locus
SPA
gene SPA description
Pt1
FC
Pt
1p v
Pt2
FC
Pt
2p v
Pt3
FC
Pt
3p v
Pathogenesis/Cellular processes SPA0452 mntH Manganese transport protein MntH 3.11 0.0459 2.06 0.0265 2.75 0.0196
SPA2748 spaP Secretory protein (associated with virulence) 10.93 0.0027 1.36 0.0400 2.03 0.0379
Amino acid biosynthesis SPA0426 cysM Cysteine synthase B 5.39 0.0340 3.66 0.0468 2.24 0.0323
Biosynthesis of cofactors,
prosthetic groups, and carriers
SPA2972 yggH Conserved hypothetical protein 7.43 0.0027 1.47 0.0445 1.51 0.0335
SPA4001 thiC Thiamine biosynthesis protein 3.48 0.0099 2.67 0.0253 2.78 0.0496
Cell envelope SPA3474 yhjN Putative polysaccharide biosynthesis protein
subunit B
4.46 0.0034 3.99 0.0386 4.25 0.0181
Central intermediary
metabolism
SPA0545 nuoK NADH dehydrogenase I chain k 9.54 0.0047 5.70 0.0295 3.97 0.0193
Energy metabolism SPA0406 eutJ Putative ethanolamine utilization protein EutJ 7.73 0.0029 7.96 0.0391 3.04 0.0250
SPA0410 eutB Ethanolamine ammonia-lyase heavy chain 5.07 0.0031 3.05 0.0322 2.40 0.0228
SPA0828 pduG PduG protein 10.54 0.0030 2.91 0.0244 3.86 0.0220
SPA3394 gntR Gluconate utilization operon repressor 9.75 0.0027 1.16 0.0403 2.09 0.0206
SPA3527 yiaR Putative sugar-phosphate isomerase 3.62 0.0446 7.61 0.0363 6.29 0.0497
SPA3706 atpA ATP synthase alpha subunit 3.76 0.0470 2.90 0.0487 1.03 0.0335
SPA4097 nrfD Cytochrome c-type biogenesis protein 11.04 0.0034 2.92 0.0256 3.84 0.0284
SPA4125 dmsC Putative dimethyl sulfoxide reductase subunit C 9.98 0.0026 1.60 0.0495 1.45 0.0317
Fatty acid and phospholipid
metabolism
SPA1655 acpP Acyl carrier protein 9.57 0.0068 3.04 0.0237 3.05 0.0392
Hypothetical proteins SPA1739 yccD Conserved hypothetical protein 2.87 0.0041 2.45 0.0278 3.82 0.0461
Mobile and extrachromosomal
element functions
SPA3373 - Conserved hypothetical protein 13.19 0.0037 1.95 0.0248 3.66 0.0326
Protein fate SPA2315 secF Protein-export membrane protein SecF 5.30 0.0030 1.49 0.0292 1.01 0.0348
SPA2496 - ClpB-like protein 6.25 0.0125 2.27 0.0328 3.09 0.0203
SPA3012 hybF Hydrogenase-2 component protein 5.51 0.0028 6.58 0.0281 5.56 0.0212
Protein synthesis SPA3288 rpmD 50S ribosomal subunit protein L30 7.81 0.0029 4.42 0.0275 3.47 0.0217
SPA3289 rpsE 30S ribosomal subunit protein S5 7.16 0.0042 4.19 0.0276 4.03 0.0196
SPA3290 rplR 50S ribosomal subunit protein L18 5.42 0.0028 4.94 0.0272 4.03 0.0213
SPA3291 rplF 50S ribosomal subunit protein L6 3.70 0.0463 1.98 0.0332 4.53 0.0225
SPA3304 rplW 50S ribosomal subunit protein L23 11.35 0.0036 5.71 0.0429 5.62 0.0273
SPA3305 rplD 50S ribosomal subunit protein L4 13.12 0.0094 3.77 0.0245 2.88 0.0185
SPA4208 rpsF 30s ribosomal protein S6 9.06 0.0025 5.87 0.0234 4.46 0.0205
Regulatory functions SPA0293 yfhH Putative transcriptional regulator 4.78 0.0367 2.40 0.0259 2.81 0.0338
SPA0905 yedE Putative membrane protein 3.68 0.0056 5.55 0.0294 3.51 0.0261
Transport and binding SPA0056 oadA Oxaloacetate decarboxylase alpha chain 7.21 0.0037 2.45 0.0259 2.38 0.0201
SPA0918 yecC Putative ABC transport ATP-binding protein 2.43 0.0035 4.01 0.0256 2.64 0.0262
SPA1531 celB PTS system, cellobiose-specific IIC component 9.19 0.0028 2.88 0.0274 2.39 0.0294
SPA2035 kdpA Potassium-transporting ATPase A chain 6.80 0.0032 5.58 0.0268 2.95 0.0499
SPA3536 mtlA Mannitol-specific enzyme II of phosphotransferase
system
6.24 0.0035 1.11 0.0285 4.39 0.0272
Unclassified SPA0411 eutC Ethanolamine ammonia-lyase light chain 8.68 0.0217 3.42 0.0295 1.50 0.0450
Unknown function SPA0409 eutA Putative ethanolamine utilization protein EutA 8.48 0.0028 9.61 0.0286 4.76 0.0265
Pseudogene SPA2109 dpiB Sensor kinase DpiB pseudogene 4.64 0.0333 1.85 0.0333 1.75 0.0252
SPA3223 - Possible membrane transport protein pseudogene 11.35 0.0044 2.08 0.0262 2.80 0.0249
SPA3638 uhpC Regulatory protein pseudogene 7.43 0.0029 3.61 0.0246 2.09 0.0335
SPA3755 rhlB Putative ATP-dependent RNA helicase pseudogene 5.03 0.0341 1.43 0.0315 2.18 0.0260
SPA: S. Paratyphi A.
FC: Fold change - ratio of signal intensities (in vivo/in vitro).
PV: P value.
doi:10.1371/journal.pntd.0000908.t002
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the intestinal epithelium.
In conclusion, we have used a capture-amplification and
microarray approach to assess gene expression for a human-
restricted pathogen, S. Paratyphi A, directly in the blood of
infected humans. We detected transcripts of many genes contained
within known Salmonella pathogenicity islands and genes controlled
by the PhoPQ, RpoS and SlyA regulons required for intra-
macrophage survival. We detected expression of many genes
involved in energy metabolism, nutritional acquisition, protein
Figure 3. Quantitative-PCR mRNA expression profiles. Quantitative-PCR mRNA expression profiles during in vitro and in vivo growth of S.
Paratyphi A of genes associated with significantly different levels of detection in in vivo versus in vitro samples using SCOTS-array analysis.
Quantitative RT-PCR gene profiles of S. Paratyphi A genes (A–E) comparing RNA recovered from blood of bacteremic patients to in vitro cultures, and
a house-keeping gene with no differential expression by SCOTS-microarray analysis (F). Mean copies of mRNA per copy of 16S rRNA, standard error of
the mean (SEM), and fold-induction (G) are presented. * p,0.05; { p,0.01; { p,0.001.
doi:10.1371/journal.pntd.0000908.g003
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transport and binding, regulation, SOS responses, and antimicro-
bial resistance. These functional categories may reflect bacterial
modifications required for survival within infected humans. Of
note, we also identified expression of a large number of genes with
currently unknown function. We further identified a subset of
genes whose transcripts had altered detection in in vivo versus in
vitro samples, suggesting potential regulation of these genes within
the human host, and we confirmed induction of a subset of these
genes in vivo. The variability between patients that we observed
may relate in part to the low level of bacterial mRNA present,
variations introduced by our capture and amplification technol-
ogy, differences in infecting strains or growth phase in vivo, and
differences in bacterial location (intra-macrophage versus extra-
cellular). Despite this variability, our results have given insight into
bacterial responses in humans infected with S. Paratyphi A, and
have identified genes for future analysis, including drug target
development. These results suggest that similar approaches may be
applied to other pathogens in infected humans and animals.
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